International Life Sciences Awards 2021

4 GHP / International Life Sciences Awards 2021 , The biotechnology industry has become a huge sector, of which there are many different companies and funds all dedicated to finding cures and treatments. Led by Dr Sven Rohmann, Suenos Advisors Establishment has become a brilliant example of a hard- working and successful company in the industry. This has meant that Founder Sven has won the best expert award in Switzerland. Here we take a look at his journey to success. Biotech Investments Expert of the Year (Switzerland): SvenRohman Biotechnology is made up of the most up-to-date, modern, and cutting-edge technology in the medical field. It uses cells and DNA to enhance patient’s quality of life whilst alleviating the experience of pain and suffering in the individual. With Dr Sven Rohmann’s special mixture of scientific, pharmaceutical, and biotechnology knowledge, he has ventured into the dark waters of pharmaceutical studies. With strong research and interpersonal skills, he has built a sturdy company that has extensive contacts within the sector, as well as outside of the industry. This includes, but is not limited to, health care providers, academics, and government research administrators. After spending 10 years at a healthcare company, Merck Serono, Sven has made a difference to the industry with his focused and dedicated work. Merck Serono also aims to change and enrich people’s lives Jun21440 and it is obvious that Sven is on a path to do just that. Merck has been working on injections that treat conditions such as cancer and MS, alongside being a leader in fertility treatments, and has been investing in holistic research for some time now. Through his time with Merck, he managed the establishment of Merck Oncology and built an extensive asset portfolio that included the successful licensing of Erbitux. When leaving Merck to become the Managing Partner of Nextech Venture in Switzerland, he decided to raise funds to return up to eight times the revenue to its investors. Following this, Sven was responsible as Venture Capital Fund Manager for a Novartis Pharma capital fund and he gained much experience with many European, American and Canadian SME’s. From 2010 to 2014, Sven was the General Manager of Europe’s Burrill and Co. He then served as the Founding CEO of Ganymed Pharmaceuticals, which was sold to Astellas in 2016 when he then founded Suenos. For these biopharmaceutical companies with the mission of revolutionizing treatments by developing a new class of therapeutic drugs, the market is highly competitive, but in the grand scheme of things, we are all looking forward to reaching a goal of managing or eradicating conditions such as cancer, Alzheimer’s, and Parkinson’s etc. For Suenos, it has a great leader with the pharmaceutical experience needed to create something that is going to flourish and adapt to the market when things fluctuate. With a detailed knowledge of global research and development, as well as European Medicines Agency/